It refers to using GLP-1 receptor agonists in patients who have multiple chronic conditions, such as diabetes, cardiovascular disease, and obesity
Yes, in February 2026, the FDA approved Ozempic as the new proprietary name for the oral semaglutide tablet formulations of 1.5 mg, 4 mg, and 9 mg for adults with T2DM
People who use the appetite suppression as an opportunity to improve dietary quality, choosing nutrient-dense foods , adequate protein, and appropriate fiber, tend to see better and faster results than those who simply eat smaller portions of the same calorie-dense foods
May your blood sugar stay stable, your side effects stay manageable, and your protocols stay effective.
Decreasing Sugar Intake : A diet high in sugar can disrupt insulin, leptin, and ghrelin levels in the body